Next Up

Biomarkers US: In-Person

03 - 04 October 2022 |

San Diego, USA

03 - 04 October 2022

San Diego, USA

Gain a US perspective on the latest technologies and novel biomarkers driving forward translational research and precision medicine

01 Nov 2022
Tue, 01 November 2022

Biomarker Analysis Europe: In-Person

Hear from and meet with the leading figures in biomarker analysis to explore how companies are innovating in biomarker analysis

22 Nov 2022
Tue, 22 November 2022

Upcoming Biomarkers OwlStone Medical Webinar

Presented by OwlStone Medical

07 Dec 2022
Wed, 07 December 2022

Biomarkers for NASH Symposium

Designed to deliver the latest insights on advancing NASH therapeutic development and diagnosis through non-invasive biomarker strategies

Highlights

The Biomarker Factory
Commentary
Amanda Heslegrave, Senior Research Fellow at the UK Dementia Research Centre, UCL, showcases cutting-edge microfluidics and clinical oncology research at Biomarkers UK 2021.
31 July 2022
Biomarkers for Clinical Development
Insight Article
Edited by Tia Byer |
04 Jul 2022
Biomarker Technologies

In-Depth

Commentary
Amanda Heslegrave, Senior Research Fellow at the UK Dementia Research Centre, UCL, showcases cutting-edge microfluidics and clinical oncology research at Biomarkers UK 2021.
31 July 2022
Commentary
The Genomics Organisation for Academic Laboratories – known also to the world as GOAL – is a collaborative project set up by a group of academic centres across the United States to facilitate affordable next generation sequencing. The long-term target is to expand patient access to personalised genomic testing, as well as future biomarker discovery.
30 July 2022
Insight Article
Erin Newburn, Senior Director, Field Applications Scientist at Personalis, Inc. showcases the Personalis NeXT Platform ®, a tumour profiling solution for both tissue and liquid biopsies at Biomarkers UK 2022.
04 July 2022
Discussion Group Report
Anna Lyubetskaya, Senior Principal Scientist at Bristol Myers Squibb, leads a discussion on the industry landscape and ‘Current Status of Omics-Based Biomarkers.’
30 June 2022

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login

Stay up to date

Sign up for our monthly Editorial Newsletter to keep up with all things Biomarkers